Drugs / CyMVectin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02594566 | Nov 2015 → Aug 2016 | cytomegalovirus infection | Virginia Commonwealth University | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CyMVectin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02594566 ↗ |
| Modality | Vaccine | “prophylactic Cytomegalovirus Plasmid DNA Vaccine” NCT02594566 ↗ |
| Route | Intramuscular | “unilateral intramuscular (IM) injection” NCT02594566 ↗ |